Replies to post #2264 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>surprised to hear (recently) that some G5 launches had not yet occurred.<

Launching a drug is Europe is sloooooow. If it gets done in less than a year from the EU approval for marketing, that’s not bad, relatively speaking.

Sebivo is launched in the UK and Germany, but not yet in France, Italy, and Spain. The one-year anniversary of EU approval is April 30.